FOXC1 knockdown engenders a decelerated growth rate within the FOXC1 knockdown group, evident from the CCK8 assay, and corroborated by tumor size and weight differentials in the in vivo comparison with the control group. This evidence concerns the gene FOXC1 and neoplasm.